Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$49.62 - $58.13 $573,458 - $671,808
-11,557 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$48.27 - $65.25 $20.9 Million - $28.2 Million
-432,248 Reduced 97.4%
11,557 $644,000
Q4 2021

Feb 14, 2022

BUY
$59.5 - $67.25 $3.02 Million - $3.42 Million
50,826 Added 12.93%
443,805 $29 Million
Q3 2021

Nov 12, 2021

BUY
$60.19 - $75.29 $1.08 Million - $1.35 Million
17,877 Added 4.77%
392,979 $25.6 Million
Q2 2021

Aug 16, 2021

BUY
$62.12 - $74.2 $852,410 - $1.02 Million
13,722 Added 3.8%
375,102 $27.6 Million
Q1 2021

May 17, 2021

BUY
$57.98 - $73.08 $48,239 - $60,802
832 Added 0.23%
361,380 $22.2 Million
Q4 2020

May 17, 2021

BUY
$62.61 - $71.29 $16.5 Million - $18.8 Million
264,174 Added 274.11%
360,548 $25.7 Million
Q4 2020

Feb 16, 2021

SELL
$62.61 - $71.29 $11.1 Million - $12.6 Million
-176,551 Reduced 64.69%
96,374 $6.87 Million
Q3 2020

Nov 16, 2020

BUY
$51.39 - $72.41 $6.85 Million - $9.65 Million
133,332 Added 95.51%
272,925 $19 Million
Q2 2020

Aug 14, 2020

BUY
$39.55 - $54.65 $1.51 Million - $2.08 Million
38,144 Added 37.6%
139,593 $7.4 Million
Q1 2020

May 14, 2020

SELL
$34.75 - $45.85 $882,198 - $1.16 Million
-25,387 Reduced 20.02%
101,449 $4.09 Million
Q4 2019

Feb 14, 2020

SELL
$36.66 - $41.78 $54,403 - $62,001
-1,484 Reduced 1.16%
126,836 $5.15 Million
Q3 2019

Nov 14, 2019

BUY
$34.82 - $39.26 $68,978 - $77,774
1,981 Added 1.57%
128,320 $4.86 Million
Q2 2019

Aug 15, 2019

SELL
$36.05 - $42.76 $27,325 - $32,412
-758 Reduced 0.6%
126,339 $4.73 Million
Q1 2019

May 14, 2019

BUY
$35.77 - $40.57 $4.55 Million - $5.16 Million
127,097 New
127,097 $5.15 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.33B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.